Stocks · Korea 340450 KOSDAQ

GC Genome

10,140원 -0.59% Market cap 2,398억 2026-10-07 close

📈 Chart & live quote

Data as of 2026-10-07 · Linked from 7 pages

An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER54.81x

PBR3.06x

EPS185 KRW

BPS3,310 KRW

ROE5.17%

Dividend yield0.00%

DPS0 KRW

Payout ratio0.00%

Returns and 52-week range

1W+16.69%

1M+87.08%

3M+111.25%

6M+26.28%

1Y+25.50%

YTD+51.80%

52W high10,380원

52W low4,100원

From 52W high-2.31%

Financial results (separate)

Period	Revenue	Operating income	Net income	OP margin
2025	315억	12억	40억	3.9%
Quarterly
2025 2Q	78억	3억	-72,972,941원	3.7%
2025 3Q	88억	8억	14억	8.8%
2026 1Q	74억	1억	8억	1.9%

Company

CEO기창석

Founded2013-07-31

Fiscal year end12

Websitewww.gcgenome.com

Address: 경기도 용인시 기흥구 이현로30번길 107

Peers in the same sector

Company	Market cap	P/E	P/B	1M
HEM파마	2,447억	—	48.57	-11.14%
지씨셀	2,389억	—	1.22	+8.33%
큐에이드	2,532억	19.81	4.46	+0.00%
DXVX	2,274억	—	2.42	+1.09%
심텍홀딩스	2,684억	—	10.47	+34.38%
큐라클	2,227억	—	5.69	+4.15%

Recent filings

2026-08-14반기보고서 (2026.06)
2026-05-15분기보고서 (2026.03)

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.